See how top analysts and institutions rate MU — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| UBS | Reiterated | Buy | $225 → $245 | 2025-10-16 |
| New Street | Downgrade | Buy → Neutral | 2025-10-14 | |
| BNP Paribas Exane | Upgrade | Underperform → Outperform | $270 | 2025-10-13 |
| UBS | Reiterated | Buy | $195 → $225 | 2025-10-08 |
| Itau BBA | Initiated | Outperform | $249 | 2025-10-07 |
| Morgan Stanley | Upgrade | Equal-Weight → Overweight | $220 | 2025-10-06 |
| BofA Securities | Reiterated | Neutral | $140 → $180 | 2025-09-24 |
| Mizuho | Reiterated | Outperform | $182 → $195 | 2025-09-24 |
| Wedbush | Reiterated | Outperform | $200 → $220 | 2025-09-24 |
| Citigroup | Reiterated | Buy | $175 → $200 | 2025-09-24 |
| Stifel | Reiterated | Buy | $173 → $195 | 2025-09-24 |
| KeyBanc Capital Markets | Reiterated | Overweight | $160 → $215 | 2025-09-24 |
| Rosenblatt | Reiterated | Buy | $200 → $250 | 2025-09-24 |
| Piper Sandler | Reiterated | Overweight | $165 → $200 | 2025-09-24 |
| Cantor Fitzgerald | Reiterated | Overweight | $185 → $200 | 2025-09-24 |
| TD Cowen | Reiterated | Buy | $180 → $200 | 2025-09-24 |
| UBS | Reiterated | Buy | $185 → $195 | 2025-09-24 |
| JP Morgan | Reiterated | Overweight | $185 → $220 | 2025-09-24 |
| Barclays | Reiterated | Overweight | $175 → $195 | 2025-09-24 |
| Needham | Reiterated | Buy | $150 → $200 | 2025-09-24 |
| Wells Fargo | Reiterated | Overweight | $170 → $220 | 2025-09-24 |
| Raymond James | Reiterated | Outperform | $150 → $190 | 2025-09-24 |
| TD Cowen | Reiterated | Buy | $150 → $180 | 2025-09-19 |
| Barclays | Reiterated | Overweight | $140 → $175 | 2025-09-19 |
| Mizuho | Reiterated | Outperform | $155 → $182 | 2025-09-16 |
| Citigroup | Reiterated | Buy | $150 → $175 | 2025-09-11 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 9 | 24 | 5 | 0 | 1 |
| October 2025 | 6 | 25 | 6 | 0 | 1 |
| September 2025 | 6 | 26 | 6 | 0 | 1 |
| July 2025 | 5 | 26 | 6 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for MU, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
